Outcomes in hospitalised patients with sepsis, severe sepsis or septic shock and reported penicillin allergy: a retrospective cohort study.

Beddow, David; Patel, Love; Smith, Claire S; Kirven, Justin; Schmidt, Christine; Ruppman, Daniel; Kethireddy, Rajesh; Wankum, Michael et al. · BMJ Open · 2022

retrospective_cohort · Level III

Where this comes from

Abstract

To determine outcomes in hospitalised patients with sepsis and reported penicillin allergy (PcnA). Observational retrospective cohort study using data from electronic health records. A large single health system with 11 hospitals of small, medium and large sizes including a 630-bed tertiary care teaching hospital. Patients (n=5238) ≥18 years of age, hospitalised with sepsis, severe sepsis or septic shock between 1 January 2016 and 31 December 2018, received antibacterial agents, and had documented PcnA status. Patients <18 years of age at admission were excluded. Primary outcomes evaluated were inpatient mortality and 30-day mortality posthospital discharge. Secondary outcomes were hospital length of stay, 30-day readmissions, duration of antibiotic use, rate of <i>Clostridium difficile</i> infection and total cost of care. There was no difference in outcomes including inpatient or 30-day mortality, hospital length of stay, in-hospital antibiotic duration, <i>C. difficile</i> infection, total cost of care and 30-day readmission rate between patients labelled with a PcnA vs patients who did not report PcnA (non-PcnA). In this retrospective single health system study, there was no difference in key outcomes including inpatient or 30-day mortality in patients admitted with sepsis and reported PcnA compared with patients who reported no PcnA.

Medical subject headings